Many workers have confirmed the original observation of Darling, Di Sant'Agnese, Perera and Andersen (1953) that sweat sodium and chloride levels in children with fibrocystic disease of the pancreas are three to four times higher than those found in normal children. The reason for this has not yet been defined, but the difference is so clear in children that the 'sweat test' has become one of considerable diagnostic value.
However, the normal variation of sweat sodium and chloride levels in adults and in persons of varying age from childhood into adolescence and adult life has not been so clearly defined. Despite the absence of sound data of this type there is an increasing volume of literature in which the authors interpret small variations in these levels as an indication of abnormality in the groups of persons concerned. For instance, Di Sant'Agnese, Darling, Perera and Shea (1953) and Smoller and Hsia (1959) state that a proportion of parents and siblings of children with fibrocystic disease of the pancreas have somewhat raised sodium and chloride levels and that this indicates their carrier or heterozygous state; Hsia, Driscoll, Greenberg, Lee and Lanoff (1958) state that patients with allergies, particularly asthma, show higher levels than other children; Wood, Fishman, Reemtsma, Barker and Di Sant' Agnese (1959) state that some adult patients with chronic chest disease such as chronic obstructive pulmonary emphysema show raised levels and should be considered 'formes frustes' of fibrocystic disease of the pancreas.
Earlier work (Anderson and Freeman, 1958) , in which a small group of parents and siblings were compared each with a group of normal adults and children failed to show any difference between the sweat sodium and chloride levels in the corresponding groups, but it did indicate that the levels in adults tended to be higher than those in children.
This work has been extended to include groups of greater numbers, primarily to delineate the sweat sodium and chloride levels throughout life. These levels have then been compared at the corresponding ages with those obtained in larger groups of parents and siblings of patients with fibrocystic disease. The levels in children with chronic or recurrent chest disease, including asthma, have also been compared with those of children of similar ages free from chest illnesses.
Materials and Method Method. Sweating was stimulated by an intradermal injection of mecholyl hydrochloride, as described in an earlier publication (Anderson and Freeman, 1958) ; 2 mg. mecholyl was injected intradermally on the forearm in adults and older children and a smaller dose in babies and young children. Sweat was collected for one hour.
Sodium was measured by flame photometry. This estimation can be accurately made in amounts of sweat as small as 50 mg., which was all that could be obtained from some very young infants. In the majority of instances at other ages, over 100 mg. was obtained. Chloride was determined by the method of Schales and Schales. Owing to the relative inaccuracy of titration when chloride levels are low and small amounts of sweat are collected, sodium levels are considered to be the most reliable. Therefore sodium figures only are presented in this paper. There would be no difference in the general pattern of results if chloride figures were also presented but for the sake of clarity and accuracy they are not detailed here. In our previous publication the level of 70 mEq./l. was chosen as the upper limit of normal and the lower limit of the fibrocystic level, but greater experience has shown that the vast majority of non-fibrocystic children under 15 years give values below 60 mEq./l. sodium, whilst a small percentage of fibrocystic values lie between 60 and 70 mEq./l. Consequently a dividing level at 60 mEq./l. is now taken but all results between 60 and 70 mEq./l. are checked.
Clinical Material. The following seven groups were studied:
1. One hundred patients with fibrocystic disease of the pancreas; these were all patients cared for medically 581 One hundred children up to 15 years of age used as controls; some of these children showed no organic disease and were tested purely as controls. The others were referred for diagnosis and showed conditions such as coeliac disease, steatorrhoea or failure to thrive. No child with subacute, recurrent or chronic chest symptoms is included in this group. Stools were always examined for excess fat in those who had failed to thrive and all children with steatorrhoea were shown to have normal pancreatic enzymes.
3. One hundred children up to 15 years of age who showed symptoms of subacute, recurrent, or chronic chest disease, but no digestive upsets or clinical evidence of pancreatic deficiency; these children comprise, first, a group, of whom the majority were infants, who were referred for a diagnostic sweat test because they had recurrent attacks of pneumonia or bronchitis; second, a group of patients with proven suppurative bronchiectasis all treated for a number of years by Dr. Howard Williams of the Royal Children's Hospital Chest Clinic; and third, a smaller group of children with chronic asthma who were also patients of the chest clinic.
4. Sixty-one siblings of the patients with fibrocystic disease of the pancreas; these were all under 15 years of age, were healthy, had grown normally and were within normal limits when examined clinically but did not undergo any other test to exclude fibrocystic disease of the pancreas.
5. One hundred adults over 20 years of age with no known disease; these were personnel working in the hospital and relatives and friends of the Clinical Research Unit staff.
6. One hundred parents of the patients with fibrocystic disease of the pancreas; these were all over 20 years of age and did not complain of any persistent diarrhoea or chronic cough.
7. Forty-seven adolescents between 15 and 20 years with no known disease; these were young nurses, office workers, laboratory technicians and school children.
Results All groups contained individuals of both sexes in roughly equal numbers, but no difference in sodium or chloride levels was noted between the sexes, although men usually produced a larger volume of sweat than women. Results are given with no further reference to sex.
Among the 100 whose diagnosis was considered to be that of fibrocystic disease of the pancreas and who were all under 15 years of age when first tested, all but five showed levels of sodium and chloride above 60 mEq./litre by the method employed. Sodium results are included in Table 1 where the actual number of children showing various levels are indicated. The two children whose sodium levels are between 20 and 30 mEq./ litre were tested twice with similar results. They show other characteristics of the disease, are sisters, have pancreatic achylia and persistent suppurative chest infection of the type so familiar in this disease. The three children with sodium levels between 50 and 60 mEq./litre all have chloride levels above 60 mEq./litre. These children were retested with similar findings in one and higher results in the other two. However, the results recorded are the first performed, as is so with all groups. It can be seen that 95 % of sodium values are higher than 60 mEq./litre, 61 % being higher than 90 mEq./litre. The results from the 100 normal adults (Table 2 ) and (Fig. 2) Fig. 2) . Fig. 2 gives the scatter of results of children, adolescents, adults and parents and indicates clearly the gradual increase in levels with age, the greater number of higher results after puberty as well as the wide variation of values in adult life. 100. (1957, 1959) , and Smoller and Hsia (1959) who consider that levels of sodium and chloride in the sweat of some parents and siblings are higher than normal from which they deduce that these individuals are carriers of the abnormal gene of fibrocystic disease; and Hsia et al. (1958) who consider that children with chronic or allergic chest disease show higher levels than normal children. Our results, using a much wider range of controls, show no evidence to support these views. It is difficult to reconcile these varying results, but there are some factors which can be discussed.
A possible criticism of our results is that the method of obtaining sweat is not a satisfactory one. Among workers in the field of sweat electrolytes in fibrocystic disease of the pancreas a variety of methods have been used to stimulate sweating, but these fall broadly into two classes: sweating stimulated by heat or by other chemical agents. Results recorded by Di Sant'Agnese and his group and Hsia and co-workers are those of heat sweat. In the present study the method of sweat stimulation by intradermal mecholyl has been chosen for reasons outlined in a previous publication (Anderson and Freeman, 1958) . As pointed out in that paper, the levels of sodium and chloride in sweat obtained in this way may be somewhat higher, occasionally up to 20 mEq./litre, than in sweat obtained by heat stimulation. However, this choice of method does not significantly affect the results obtained in the present study because all tests were done in the same way and can therefore be compared with each other, although not necessarily with those of other workers.
It might be possible that heat sweat produces a different pattern of values. However, study of the literature relating to normal sweating reveals a wide divergence in the range of results of sodium and chloride obtained by many workers. Notable amongst these references are the review by Robinson and Robinson (1954) and the monograph on 'Human Perspiration' by Kuno (1956 Kuno' s statement that age may be one of the factors and that about puberty there may be some physiological alteration in the control mechanism, or the factors that influence the concentrations may be playing a greater part, perhaps the endocrine factors. In view of the confusion that exists regarding the precise limits of normal variation of sweat sodium and chloride concentration in adults and the limitations of knowledge regarding the physiological control of these electrolyte levels, it is unwise to draw conclusions from the rather minor differences which some workers have observed in a proportion of parents and siblings of patients with fibrocystic disease and in some patients with chronic chest disease. In the work of both Di Sant'Agnese's group and Hsia and co-workers small groups of control adults are mentioned, but no attention paid to variation over a wide range of age.
A study of the literature devoted to the sweat sodium and chloride levels in patients with fibrocystic disease of the pancreas shows that differing levels are given by several authors as the upper limit of normal. The original contribution of Darling et al. (1953) Shwachman and Leubner (1955) .
As there is still such variation among workers regarding the upper limit of normal for heat sweat it does not seem reasonable to theorize over levels between 50 and 70 mEq./litre obtained in parents and siblings (Smoller and Hsia, 1959) , children with allergic chest conditions (Hsia et al., 1958) , or adults with chronic chest disease (Petersen, 1959) .
The abnormal gene for fibrocystic disease of the pancreas appears to be a reasonably frequent one in the community and it might be argued that the adults and parents who showed values over 60 mEq./litre in this paper were all heterozygotes. However, between 30 and 40% of both groups of adults tested came into this category and not even the most enthusiastic geneticist has yet placed the carrier rate at this level. The majority opinion suggests that the incidence of this disease in communities of Caucasian origin is in the region of one in 1,000 live births (Carter, in Bodian, 1953; Childs, 1956) and consequently, as the former writer states, the carrier rate would be about one in 15 or 6-5 %.
If these higher results did indicate the carrier state then a proportion of siblings should show results in the same range, but in the data presented here they do not. Apart from the constant and clear difference between fibrocystic and non-fibrocystic children under 15 years of age there does not seem to be any other information relevant to fibrocystic disease of the pancreas than can at present be obtained from a study of the actual levels of sweat sodium and chloride, unless the reason for the varying and high levels found normally after puberty bears any relationship to the underlying defect in this disease.
As a consequence of the data presented here the determination of sweat sodium and chloride loses much of its value as a test for the diagnosis of fibrocystic disease of the pancreas in adults. We have already encountered difficulty in several adolescents and older persons who are suspected by certain clinical features of suffering from this disease. In these a very careful assessment of all features relevant to the disease should be made. As yet, there is insufficient evidence for the postulation of 'formes frustes' of the disease, but this will be discussed in more detail in a future publication.
The sweat abnormality or the abnormality of exocrine secretions in fibrocystic disease of the pancreas cannot yet be explained in basic terms, and until this can be done, slight abnormalities of sweat electrolytes should not be regarded as a genetic manifestation of the disease. Theorizing in this regard has preceded precise basic knowledge, and may give rise to misleading genetic counselling.
Summary
The range of sweat sodium and chloride levels obtained by stimulation with mecholyl in normal persons from birth to old age has been determined. A slight increase in concentration of these electrolytes has been found with increasing age in childhood. There is a greater increase and variation at and after puberty.
No difference has been observed in the results from 100 normal adults over 20 years of age and 100 parents of fibrocystic children.
No difference has been observed in the results from 61 healthy siblings of fibrocystic children and other children up to 15 years of age.
No difference has been observed in the results from 100 normal children and 100 children with chronic chest illness other than fibrocystic disease of the pancreas.
These results do not provide evidence that the carrier state in fibrocystic disease can be determined from raised levels of sweat sodium and chloride, nor that chest disorders in children show altered levels of these sweat electrolytes.
The 'sweat test' is of limited value in the diagnosis of fibrocystic disease of the pancreas in young adults or older persons.
Generalizations regarding genetic constitution in families of fibrocystic children should await further knowledge of the normal mechanism of control of sweat electrolytes and the basic defect in fibrocystic disease.
